» Articles » PMID: 36551775

The Long-Term Effects of Prenatal Hypoxia on Coronary Artery Function of the Male and Female Offspring

Overview
Journal Biomedicines
Date 2022 Dec 23
PMID 36551775
Authors
Affiliations
Soon will be listed here.
Abstract

Prenatal hypoxia predisposes the offspring to the development of cardiovascular (CV) dysfunction in adult life. Using a rat model, we assessed the effect of prenatal hypoxia on vasoconstrictive and vasodilative mechanisms in left anterior descending coronary arteries of 4- and 9.5-month-old offspring. Endothelium-dependent relaxation to methylcholine and vasoconstriction responses to endothelin-1 (ET-1) were assessed by wire myography. Prenatal hypoxia impaired endothelium-dependent vasodilation in 4- and 9.5-month-old offspring. Inhibition of nitric oxide (NO) synthase prevented coronary artery relaxation in all groups. Inhibition of prostaglandin H synthase (PGHS) improved relaxation in prenatally hypoxic males and tended to improve vasorelaxation in females, suggesting that impaired vasodilation was mediated via increased PGHS-dependent vasoconstriction. An enhanced contribution of endothelium-dependent hyperpolarization to coronary artery vasodilation was observed in prenatally hypoxic males and females. No changes in endothelial NO synthase (eNOS) and PGHS-1 expressions were observed, while PGHS-2 expression was decreased in only prenatally hypoxic males. At 4 months, ET-1 responses were similar between groups, while ET inhibition (with BQ788) tended to decrease ET-1-mediated responses in only prenatally hypoxic females. At 9.5 months, ET-1-mediated responses were decreased in only prenatally hypoxic females. Our data suggest that prenatal hypoxia has long-term similar effects on the mechanisms of impaired endothelium-dependent vasodilation in coronary arteries from adult male and female offspring; however, coronary artery contractile capacity is impaired only in prenatally hypoxic females. Understanding the mechanistic pathways involved in the programming of CV disease may allow for the development of therapeutic interventions.

Citing Articles

Sex-specific differences in the mechanisms for enhanced thromboxane A-mediated vasoconstriction in adult offspring exposed to prenatal hypoxia.

Graton M, Spaans F, He R, Chatterjee P, Kirschenman R, Quon A Biol Sex Differ. 2024; 15(1):52.

PMID: 38898532 PMC: 11188502. DOI: 10.1186/s13293-024-00627-x.


Combined Pharmacological Modulation of Translational and Transcriptional Activity Signaling Pathways as a Promising Therapeutic Approach in Children with Myocardial Changes.

Kamenshchyk A, Belenichev I, Oksenych V, Kamyshnyi O Biomolecules. 2024; 14(4).

PMID: 38672493 PMC: 11047929. DOI: 10.3390/biom14040477.


Cardioprotective Activity of Pharmacological Agents Affecting NO Production and Bioavailability in the Early Postnatal Period after Intrauterine Hypoxia in Rats.

Popazova O, Belenichev I, Bukhtiyarova N, Ryzhenko V, Oksenych V, Kamyshnyi A Biomedicines. 2023; 11(10).

PMID: 37893227 PMC: 10604160. DOI: 10.3390/biomedicines11102854.

References
1.
Graves J, Greenwood I, Large W . Tonic regulation of vascular tone by nitric oxide and chloride ions in rat isolated small coronary arteries. Am J Physiol Heart Circ Physiol. 2000; 279(6):H2604-11. DOI: 10.1152/ajpheart.2000.279.6.H2604. View

2.
Ramaswami G, Chai H, Yao Q, Lin P, Lumsden A, Chen C . Curcumin blocks homocysteine-induced endothelial dysfunction in porcine coronary arteries. J Vasc Surg. 2004; 40(6):1216-22. DOI: 10.1016/j.jvs.2004.09.021. View

3.
Baschat A, Gembruch U, Harman C . Coronary blood flow in fetuses with intrauterine growth restriction. J Perinat Med. 1998; 26(3):143-56. View

4.
Stein C, Fall C, Kumaran K, Osmond C, Cox V, Barker D . Fetal growth and coronary heart disease in south India. Lancet. 1996; 348(9037):1269-73. DOI: 10.1016/s0140-6736(96)04547-3. View

5.
Zhang L . Prenatal hypoxia and cardiac programming. J Soc Gynecol Investig. 2005; 12(1):2-13. DOI: 10.1016/j.jsgi.2004.09.004. View